Key Study
Efficacy of biologics for the treatment of periodontal infrabony defects: An American Academy of Periodontology best evidence systematic review and network meta-analysis
Lorenzo Tavelli, Chia-Yu (Jennifer) Chen, Shayan Barootchi, David M. Kim
J Periodontol. 2022 Dec;93(12):1803-1826
Disclaimer: These results are not guaranteed; individual outcomes may vary depending on patient circumstances. This information is for informational purposes only and may not reflect Geistlich’s official position, opinion, or recommendation. Treatment decisions are made at the physician’s discretion, based on the unique needs of each patient.
GEM 21S® has not been approved by the FDA for use in this indication, and the safety and effectiveness of GEM 21S® for use in this indication has not been established by the FDA.
J Periodontol. 2022 Dec;93(12):1803-1826
Disclaimer: These results are not guaranteed; individual outcomes may vary depending on patient circumstances. This information is for informational purposes only and may not reflect Geistlich’s official position, opinion, or recommendation. Treatment decisions are made at the physician’s discretion, based on the unique needs of each patient.
GEM 21S® has not been approved by the FDA for use in this indication, and the safety and effectiveness of GEM 21S® for use in this indication has not been established by the FDA.
GEM 21S®